Advancing In Vivo Chimeric Antigen Receptor T‐Cell Engineering to Accelerate Clinical Translation
A framework for understanding in vivo CAR‐T engineering is provided and key strategies for overcoming translational barriers and advancing next‐generation CAR‐T therapies are highlighted.